A detailed history of Schroder Investment Management Group transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 476,713 shares of VERA stock, worth $20 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
476,713
Previous 433,172 10.05%
Holding current value
$20 Million
Previous $15.7 Million 34.41%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$34.09 - $46.71 $1.48 Million - $2.03 Million
43,541 Added 10.05%
476,713 $21.1 Million
Q2 2024

Aug 12, 2024

BUY
$33.72 - $48.82 $2.75 Million - $3.98 Million
81,519 Added 23.18%
433,172 $15.7 Million
Q1 2024

May 14, 2024

SELL
$14.91 - $49.14 $11.3 Million - $37.3 Million
-759,307 Reduced 68.35%
351,653 $15.2 Million
Q4 2023

Feb 13, 2024

BUY
$9.29 - $16.0 $10.3 Million - $17.8 Million
1,110,960 New
1,110,960 $17.1 Million

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.13B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.